Form 4 Filing: Welgus Howard G. Acquires (Grant) shares of $ARQT

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Arcutis Biotherapeutics, Inc.

Ticker: $ARQT

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-05

Shares: 5,778

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Welgus Howard G., holds the title of Director at Arcutis Biotherapeutics, Inc..

On 2026-06-05, the insider transacted 5,778 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Welgus Howard G. (Director) was granted $0 of $ARQT

Post-Transaction Position: 38,378 shares

SEC Accession No: 0001628280-26-042044 (CIK: 1801050)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ARQT Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ARQT News Coverage